» Articles » PMID: 24630742

Impact of Primary Negative Symptoms on Functional Outcomes in Schizophrenia

Overview
Journal Eur Psychiatry
Specialty Psychiatry
Date 2014 Mar 18
PMID 24630742
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Negative symptoms are known to undermine functional outcomes in people with schizophrenia; however, most studies have not accounted for whether these symptoms were primary or secondary to other psychopathological factors. The present study examined the impact of primary negative symptoms on functional outcomes in patients with schizophrenia.

Method: The sample included 1427 patients with schizophrenia who completed the baseline visit in the CATIE study. Symptoms were assessed with the Positive and Negative Syndrome Scale and Calgary Depression Scale, extrapyramidal side effects with the Simpson-Angus scale, and functional status with the Heinrichs-Carpenter Quality of Life Scale.

Results: Negative symptoms were significantly and inversely related to each domain of functioning examined. These relationships remained after statistically controlling for the influence of potential sources of secondary negative symptoms. In addition, the relationships between negative symptoms and specific domains of functioning remained in patients who had mild/absent positive, depressive, anxiety and extrapyramidal symptoms. Negative symptoms were associated with functional outcomes even in antipsychotic-free patients.

Conclusions: Primary negative symptoms significantly contribute to the functional impairment seen in people with schizophrenia. A better understanding of the etiology and pathobiology of these symptoms is required to guide the search for effective therapeutics that promote functional recovery.

Citing Articles

Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS).

van Brouwershaven T, Poppe A, Pijnenborg G, Aleman A, Boonstra N, Gangadin S Brain Sci. 2025; 15(1).

PMID: 39851383 PMC: 11763429. DOI: 10.3390/brainsci15010015.


Social functioning and frontal alpha asymmetry in schizophrenia.

Farina E, Assaf M, Corbera S, Choi J, Yantz C, Chen C J Psychiatr Res. 2025; 182:74-82.

PMID: 39799666 PMC: 11830537. DOI: 10.1016/j.jpsychires.2025.01.006.


The Role of Defeatist Performance Beliefs in State Fluctuations of Negative Symptoms in Schizophrenia Measured in Daily Life via Ecological Momentary Assessment.

Luther L, Raugh I, Grant P, Beck A, Strauss G Schizophr Bull. 2024; 50(6):1427-1435.

PMID: 39066666 PMC: 11548930. DOI: 10.1093/schbul/sbae128.


Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial.

Yamanushi A, Shimada T, Koizumi A, Kobayashi M Biomedicines. 2024; 12(7).

PMID: 39062072 PMC: 11274551. DOI: 10.3390/biomedicines12071498.


Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia.

Boskovic D, Smith-Palmer J, Pohlmann J, Pollock R, Hwang S, Bruhn D Patient Relat Outcome Meas. 2024; 15:199-217.

PMID: 38911609 PMC: 11192194. DOI: 10.2147/PROM.S454845.